Attached files

file filename
EX-4.3 - EX-4.3 - aTYR PHARMA INCd819057dex43.htm
EX-3.1 - EX-3.1 - aTYR PHARMA INCd819057dex31.htm
EX-3.3 - EX-3.3 - aTYR PHARMA INCd819057dex33.htm
EX-4.2 - EX-4.2 - aTYR PHARMA INCd819057dex42.htm
EX-4.4 - EX-4.4 - aTYR PHARMA INCd819057dex44.htm
EX-10.6 - EX-10.6 - aTYR PHARMA INCd819057dex106.htm
EX-10.8 - EX-10.8 - aTYR PHARMA INCd819057dex108.htm
EX-10.5 - EX-10.5 - aTYR PHARMA INCd819057dex105.htm
EX-10.3 - EX-10.3 - aTYR PHARMA INCd819057dex103.htm
EX-10.9 - EX-10.9 - aTYR PHARMA INCd819057dex109.htm
EX-21.1 - EX-21.1 - aTYR PHARMA INCd819057dex211.htm
EX-10.7 - EX-10.7 - aTYR PHARMA INCd819057dex107.htm
EX-10.4 - EX-10.4 - aTYR PHARMA INCd819057dex104.htm
EX-10.1 - EX-10.1 - aTYR PHARMA INCd819057dex101.htm
EX-10.10 - EX-10.10 - aTYR PHARMA INCd819057dex1010.htm
S-1 - FORM S-1 - aTYR PHARMA INCd819057ds1.htm
EX-4.5 - EX-4.5 - aTYR PHARMA INCd819057dex45.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 3, 2015, in the Registration Statement on Form S-1 and related Prospectus of aTyr Pharma, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

San Diego, CA

April 3, 2015